Pietro Di Fazio
Pietro Di Fazio
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC
K Quint, A Agaimy, P Di Fazio, R Montalbano, C Steindorf, R Jung, ...
Virchows Archiv 459, 129-139, 2011
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib
S Emanuele, M Lauricella, D Carlisi, B Vassallo, A D’Anneo, P Di Fazio, ...
Apoptosis 12, 1327-1338, 2007
Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex
A Kastl, A Wilbuer, AL Merkel, L Feng, P Di Fazio, M Ocker, E Meggers
Chemical communications 48 (13), 1863-1865, 2012
Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition
K Quint, M Tonigold, P Di Fazio, R Montalbano, S Lingelbach, F Rueckert, ...
International journal of oncology 41 (6), 2093-2102, 2012
The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation
D Carlisi, M Lauricella, A D’Anneo, S Emanuele, L Angileri, P Di Fazio, ...
European journal of cancer 45 (13), 2425-2438, 2009
Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines
P Di Fazio, R Montalbano, D Neureiter, B Alinger, A Schmidt, AL Merkel, ...
Experimental cell research 318 (15), 1832-1843, 2012
The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis
P Di Fazio, R Schneider-Stock, D Neureiter, K Okamoto, T Wissniowski, ...
Analytical Cellular Pathology 32 (4), 285-300, 2010
DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions
M Gandesiri, S Chakilam, J Ivanovska, N Benderska, M Ocker, P Di Fazio, ...
Apoptosis 17, 1300-1315, 2012
Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation
B Behm, P Di Fazio, P Michl, D Neureiter, R Kemmerling, EG Hahn, ...
Gut 65 (1), 134-143, 2016
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects
D Carlisi, B Vassallo, M Lauricella, S Emanuele, A D'Anneo, ...
International journal of oncology 32 (1), 177-184, 2008
Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome
E Klieser, R Urbas, S Stättner, F Primavesi, T Jäger, A Dinnewitzer, ...
Human pathology 65, 41-52, 2017
Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines
S Zopf, M Ocker, D Neureiter, B Alinger, S Gahr, MF Neurath, P Di Fazio
Bmc Cancer 12, 1-10, 2012
The crosstalk of miRNA and oxidative stress in the liver: from physiology to pathology and clinical implications
E Klieser, C Mayr, T Kiesslich, T Wissniowski, P Di Fazio, D Neureiter, ...
International journal of molecular sciences 20 (21), 5266, 2019
Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer
P Di Fazio, P Waldegger, S Jabari, S Lingelbach, R Montalbano, M Ocker, ...
Oncotarget 7 (20), 28998, 2016
MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5
AI Damanakis, S Eckhardt, A Wunderlich, S Roth, TT Wissniowski, ...
Journal of cancer research and clinical oncology 142, 1213-1220, 2016
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells
C Mayr, A Wagner, M Loeffelberger, D Bruckner, M Jakab, F Berr, ...
Oncotarget 7 (1), 745, 2016
Pharmacological inhibition of class IIA HDACs by LMK-235 in pancreatic neuroendocrine tumor cells
J Wanek, M Gaisberger, M Beyreis, C Mayr, K Helm, F Primavesi, T Jäger, ...
International journal of molecular sciences 19 (10), 3128, 2018
AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors
CR Gloesenkamp, B Nitzsche, M Ocker, P Di Fazio, K Quint, B Hoffmann, ...
International journal of oncology 40 (3), 876-888, 2012
Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung
P Di Fazio, M Maass, S Roth, C Meyer, J Grups, P Rexin, DK Bartsch, ...
Tumor Biology 39 (10), 1010428317728417, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20